Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Rating of “Moderate Buy” by Analysts

Surgery Partners, Inc. (NASDAQ:SGRY) has been assigned a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, eight have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $22.1818.

A number of analysts have recently commented on the company. Zacks Research raised Surgery Partners from a “hold” rating to a “strong-buy” rating in a research note on Thursday, June 4th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Surgery Partners in a research note on Tuesday, May 26th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $17.00 target price on shares of Surgery Partners in a report on Wednesday, May 6th.

Surgery Partners Price Performance

Shares of NASDAQ SGRY traded down $0.37 during mid-day trading on Friday, reaching $16.40. 858,838 shares of the company traded hands, compared to its average volume of 1,270,023. Surgery Partners has a fifty-two week low of $11.41 and a fifty-two week high of $24.10. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.86 and a quick ratio of 1.69. The firm has a market cap of $2.14 billion, a PE ratio of -27.33, a price-to-earnings-growth ratio of 4.90 and a beta of 1.89. The stock has a fifty day simple moving average of $14.70 and a 200-day simple moving average of $14.44.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Tuesday, May 5th. The company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.12. The firm had revenue of $810.90 million for the quarter, compared to analysts’ expectations of $797.69 million. Surgery Partners had a positive return on equity of 1.04% and a negative net margin of 2.28%.The firm’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.04 earnings per share. Equities research analysts anticipate that Surgery Partners will post 0.25 EPS for the current fiscal year.

Hedge Funds Weigh In On Surgery Partners

Several hedge funds have recently made changes to their positions in SGRY. Caitong International Asset Management Co. Ltd lifted its stake in Surgery Partners by 45,640.0% during the third quarter. Caitong International Asset Management Co. Ltd now owns 2,287 shares of the company’s stock valued at $49,000 after purchasing an additional 2,282 shares during the last quarter. PNC Financial Services Group Inc. grew its position in Surgery Partners by 128.4% in the third quarter. PNC Financial Services Group Inc. now owns 2,702 shares of the company’s stock worth $58,000 after buying an additional 1,519 shares during the last quarter. Fifth Third Bancorp increased its holdings in shares of Surgery Partners by 5,324.0% in the first quarter. Fifth Third Bancorp now owns 4,068 shares of the company’s stock valued at $48,000 after buying an additional 3,993 shares in the last quarter. Aquatic Capital Management LLC bought a new position in shares of Surgery Partners in the third quarter valued at $121,000. Finally, Tower Research Capital LLC TRC lifted its position in shares of Surgery Partners by 68.7% during the 2nd quarter. Tower Research Capital LLC TRC now owns 9,313 shares of the company’s stock valued at $207,000 after acquiring an additional 3,794 shares during the last quarter.

About Surgery Partners

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.